We determined the expression of both mRNAs and microRNAs (miRNAs) from human mesenchymal stem cells BM19, FM30, and AM3, which is derived from breast, face, and abdominal adipose tissues, respectively. BM19, FM30, and AM3 cells exhibited considerably similar mRNA profiles, and their 1,038 abundantly common genes were involved in regulating six cell adhesion and three cytoskeleton remodeling processes among the top ten GeneGo canonical pathway maps. The 39 most abundant miRNAs in AM3 cells were expressed at very similar levels in BM19 cells. However, seven abundant miRNAs (miR-19b, miR-320, miR-186, miR-199a, miR-339, miR-99a, and miR-152) in AM3 cells were expressed at much lower levels than that in FM30 cells, and 38 genes targeted by these miRNAs were consequently upregulated more than 3-fold in FM30 cells compared with AM3 cells. Therefore, autologous abdominal adipose-derived mesenchymal stem cells are suitable for tissue engineering of breast reconstruction because of very similar expression profiles of mRNAs and miRNAs between AM3 and BM19 cells. Conversely, abdominal AM3 cells might not be suitable for facial rejuvenation, since the 38 highly expressed genes targeted by miRNAs in FM30 cells might play an important role(s) in the development of facial tissue.
Mesenchymal stem cells (MSCs) have been shown to have the ability to differentiate into multiple mesodermal lineages such as adipocytes, osteoblasts, and chondrocytes [1, 2] . Thus MSCs are potentially very useful for tissue engineering and regenerative medicine [3] [4] [5] .
Human MSCs have been isolated from several tissue sources, including adipose tissues [6] [7] [8] [9] [10] . Human adult adipose tissues are highly abundant and relatively easy to procure with low risk. In our laboratory, we developed a new culture method that greatly accelerates the growth rate and prolongs the life span of human adipose-derived MSCs (hAD-MSCs) using a growth medium with low calcium and supplemented with the antioxidants N-acetyl-L-cysteine and L-ascorbic acid [6] . Furthermore, hAD-MSCs isolated using this newly developed method from abdominal subcutaneous adipose tissue were used successfully to regenerate in vivo new adipose tissue of predefined shape and three-dimensions on scaffolding made with three commonly used biomaterials [11] .
Genome-wide mRNA expression profiling has recently been used to identify the core features of several MSCs and the signature genes of each group of MSCs derived from different origins [12] [13] [14] . MicroRNAs (miRNAs) that are single-stranded non-coding RNAs of approximately 22 nucleotides have been identified in various organisms, including mammals. Mammalian genomes encode many hundreds of miRNAs, which are predicted to regulate negatively expression of as many as 30% of protein-coding genes [15] [16] [17] . Although the biological functions of most miRNAs are unclear, some miRNAs appear to participate in controlling cell proliferation, differentiation, and apoptosis in animals [18, 19] . Thus miRNAs may play key roles in self-renewal and differentiation of MSCs.
Tissue engineering using hAD-MSCs derived from abdominal adipose tissue may be a promising method to generate new tissues for tissue restorations such as breast reconstruction and facial rejuvenation. Therefore, it important to compare the molecular characteristics of hAD-MSCs derived from breast, face, and abdominal adipose tissues. In this investigation, the expression profiles of both mRNAs and miRNAs from the same RNA samples of hAD-MSCs newly isolated from breast and face adipose tissues (designated as BM19 and FM30) were compared with those of previously reported hAD-MSC3 derived from abdominal adipose tissue (designated as AM3) [20] to understand the genetic bases for their similarities and differences.
METHODS

Cell culture
Human hAD-MSCs BM19 and FM30 were newly isolated from breast and face adipose tissues, respectively, as previously described [8, 11, 20] . The patients gave informed consent and Institutional Review Board approval was obtained by Kaohsiung Medical University Hospital. These hAD-MSC cells were cultured in K-NAC medium that is a modified MCDB 153 medium (Keratinocyte-SFM; GIBCO-Invitrogen Corp., Carlsbad, CA, USA) supplemented with 2 mM N-acetyl-L-cysteine (A8199; Sigma, St. Louis, MO, USA) and 0.2 mM L-ascorbic acid 2-phosphate (A8960; Sigma).
Profiling of mRNAs
Total RNAs from BM19 and FM30 cells were extracted using TRIZOL reagent (Invitrogen), and the same total RNAs from each sample were used for both mRNA microarray analysis and miRNA quantitation. The mRNA profiling of duplicate samples was analyzed using Affymetrix Human Genome U133 plus 2.0 GeneChip ® according to the manufacturer's protocols (Santa Clara, CA, USA) and the Microarray Core Facility of National Research Program for Genomic Medicine of the National Science Council in Taiwan. This Affymetrix GeneChip ® contains 54,675 probe sets to analyze the expression level of 47,400 transcripts and variants, including 38,500 well-characterized human genes. GeneChips from the hybridization experiments were read by the Affymetrix GeneChip ® scanner 3000. The original data were processed using the GC-RMA algorithm and GeneSpring GX software version 7.3.1 (Silicon Genetics, Redwood City, CA, USA). The Affymetrix GeneChip ® expression analysis can be used as a stand-alone quantitative comparison as the correlation between Affymetrix GeneChip ® results and TaqMan real-time polymerase chain reaction (PCR) results show good linearity of R 2 = 0.95 by the MicroArray Quality Control Study-a collaborative effort of 137 scientists led by the US Food and Drug Administration [21, 22] . The mRNAs of BM19, FM30, and AM3 [8, 11, 20] cells were also analyzed for network and signaling pathways using MetaCore analytical suite (GeneGo Inc., St Joseph, MI, USA). The MetaCore includes a curated database of human protein interaction and metabolism, and thus it is useful for analyzing a cluster of genes in the context of regulatory network and signaling pathways.
Profiling of miRNAs
The expression levels of 250 human miRNAs were determined using the TaqMan MicroRNAAssay (Applied Biosystems, Foster City, CA, USA) as described previously [20, [23] [24] [25] . In brief, TaqMan MicroRNA Assays include two steps: stem loop reverse transcription (RT) followed by real-time quantitative PCR. (90 ng/ Rx with 24-multiplex primers) Each 10 uL RT reaction that includes 90 ng total RNA, 50 nM stem-loop RT primers, 1 × RT buffer, 1.25 mM each of dNTPs, 0.25 U/uL RNase inhibitor, and 10 U/uL MultiScribe Reverse Transcriptase was incubated in a PTC-225 Peltier Thermal Cycler (MJ Research, Watertown, MA, USA) for 30 minutes each at 16°C and at 42°C, followed by 5 minutes at 85°C, and then maintained at 4°C. RT products were diluted 20 times with dH2O prior to setting up the PCR reaction. Real-time PCR for each miRNA was carried out in triplicate, and each 10 uL reaction mixture included 2 uL of diluted RT product, 5 uL of 2 × TaqMan Universal PCR Master Mix and 0.2 uM TaqMan probe. The reaction was incubated in an Applied Biosystems 7900HT Sequence Detection System at 95°C for 10 minutes, followed by 40 cycles of 95°C for 15 seconds and 60°C for 1 minute. The threshold cycle (Ct) is defined as the fraction cycle number at which the fluorescence exceeds the fixed threshold of 0.2. Total RNA input was normalized based on the Ct values of the TaqMan U6 snRNA assay as an endogenous control. The fold change was calculated as 2 −⌬Ct × K, where ⌬Ct = [Ct miRNA − Ct U6 snRNA ] and K is a constant.
Target identification of miRNAs
The potential target genes of miRNAs were predicted using the TargetCombo open source software [26] which predicts targets by the union of miRanda [27] , PicTar [28], and TargetScanS [29] with a cutoff p value < 0.05 [30] . The impact of miRNAs on protein output recently showed that although some targets are repressed without detectable changes in mRNA levels, those translationally repressed by more than a third also display detectable mRNA destabilization, and for the more highly repressed targets, mRNA destabilization usually comprises the major component of repression [17] . Therefore, comparative profiling of miRNAs and mRNAs from the same samples of different cell types may identify the putative targets of miRNAs [20, 25] . The expression levels of the predicted target mRNAs were analyzed by the Volcano plot using a parametric test and Benjamini-Hochberg false discovery rate for multiple testing corrections. The differentially expressed mRNAs were defined by foldchanges of more than three and a p value cutoff of 0.05. Thus the miRNA targets were identified by inverse relationships between expression levels of miRNAs and their target mRNAs in AM3 and FM30 cells.
RESULTS
Expression profiling of mRNAs
The genome-wide mRNA expression profiles of human breast BM19 and face FM30 cells were determined using the Affymetrix human genome U133 plus 2.0 GeneChip. The mRNA expression of BM19 and FM30 cells was compared with that of abdominal AM3 cells [20] and a very similar pattern was found, with a Pearson correlation R 2 values of 0.938 and 0.920, respectively ( Figures 1A and 1B) .
When compared with AM3 cells, there were 79 genes in BM19 cells and 112 genes in FM30 cells, which are abundantly (> 20-fold of the overall mean) differentially (> 3-fold) expressed, found to be upregulated (Supplementary Tables S1 and S2). These genes included several chemokine ligands and interleukins. Conversely, there are 44 upregulated genes in AM3 when compared with BM19 cells and 54 upregulated genes in AM3, including matrix metallopeptidase 1, when compared with FM30 cell ( Supplementary  Tables S3 and S4 ).
Using MetaCore analytical suite, the 1,038 gene probes commonly expressed among AM3, BM19, and FM30 cells were found to be involved in regulating six cell adhesion processes and three cytoskeleton remodeling processes among the top ten GeneGo canonical pathway maps ( Figure 2 ).
Expression profiling of miRNAs
The expression profiles of 250 human miRNAs in BM19 and FM30 cells were quantitated using TaqMan MicroRNA Assays as described previously [20, [23] [24] [25] , and the expression level of each miRNA was indicated as fold change over U6 snRNA. The mean expression levels of triplicate analyses for 250 miRNAs from BM19 and FM30 cells were compared with that of AM3 cells [20] as shown in scatter plots ( Figures  1C and 1D ). A very close correlation (R 2 = 0.998) was found between BM19 and AM3 cells, while a much lower correlation (R 2 = 0.724) was obtained between FM30 and AM3 cells. The mean expression levels of 250 miRNAs from BM19, FM30, and AM3 cells [20] are given in Supplementary Table S5 . We found that AM3, BM19, and FM30 cells expressed extremely low levels of the embryonic stem cell-and tissue-(liver, heart, muscle, pancreas, placenta and testis) specific miRNAs. The levels of the 39 most abundantly (> 20fold U6 snRNA) expressed miRNAs in AM3 cells were compared with the corresponding values in BM19 and FM30 cells ( Table 1 ). The 39 most abundantly expressed miRNAs in AM3 cells were found to be expressed at very similar levels (< 6-fold difference for only miR-199a, miR146b, and let-7i) in BM19 cells. However, seven extremely abundantly expressed miRNAs (miR-19b, miR-320, miR-186, miR-199a, miR-339, miR-99a, and miR-152) in AM3 cells were expressed at much lower levels (down-regulated more than 800-fold) than that in FM30 cells, while miR-222 and miR-146a were up-regulated more than 400-fold and 10-fold, respectively, in FM30 cells compared with AM3 cells.
Target identification of miRNAs
The targets of seven highly downregulated miRNAs (miR-19b, miR-320, miR-186, miR-199a, miR-339, miR-99a, and miR-152) in FM30 cells compared with AM3 cells were identified by inverse relationships between expression levels of miRNAs and their target mRNAs in AM3 and FM30 cells ( Table 2 ). Thirtyeight target genes were found to be upregulated more than three-fold by the six downregulated miRNAs (except miR-99a) in FM30 cells compared with AM3 cells. Of these 38 genes, 11 genes (EREG, PAPPA, STC1, DLX1, PCDH9, LIF, PAX3, MYO16, TNFSF11, EYA4, and BEX1) were abundantly expressed in FM30 cells.
DISCUSSION
In this study, we found that the expression profiles of mRNAs from breast BM19 and face FM30 cells were very similar to that of abdominal AM3 cells. The 1,038 abundantly expressed genes among AM3, BM19, and FM30 cells indicate that six of the top 10 network and signaling pathways are involved in cell adhesion processes. These results are in agreement with previous reports that the core signature transcriptomes of human MSCs isolated from bone marrow, cord blood, 0. 00 0. 00 0. 01 0. 10 1. 00 10 .0 0 10 0. 00 1, 00 0. 00 10 ,0 00 .0 0 10 0, 00 0. 00 1, 00 0, 00 0. 00 10 ,0 00 ,0 00 .0 0 10 0, 00 0, 00 0. 00 0. 00 0. 00 0. 01 0. 10 1. 00 10 .0 0 10 0. 00 1, 00 0. 00 10 ,0 00 .0 0 10 0, 00 0. 00 1, 00 0, 00 0. 00 10 ,0 00 ,0 00 .0 0 10 0, 00 0, 00 0. 00 0.00 100.00 1,000.00 10,000.00 100,000.00 1,000,000.00
Figure 1. Scatter plots and correlation analyses of mRNAs and microRNAs among AM3, BM19, and FM30 cells. The average mRNA expression levels of duplicate samples from (A) BM19 and AM3 cells and (B) FM30 and AM3 cells. The expression levels of more or less than three-fold are indicated by lines of 3×. The Pearson correlation of mRNA expression levels between AM3 and BM19
cells was found to be R 2 = 0.938, and that of AM3 and FM30 cells was R 2 = 0.920. The microRNA expression levels from (C) BM19 and AM3 cells; and (D) FM30 and AM3 cells. The Pearson correlation of microRNA expression levels between AM3 and BM19 cells was found to be R 2 = 0.998, and that of AM3 and FM30 cells was R 2 = 0.724.
amniotic fluid, and amniotic membranes include genes involved in the regulation of the extracellular matrix and adhesion [14, 31] . Human miRNA changes during MSC differentiation have recently been studied, and 27 miRNAs were identified as being regulated during differentiation into adipocytes, osteocytes, or chondrocytes [32] .
We found that the miRNA expression profile of BM19 cells was extremely similar to that of AM3 cells, but the miRNA expression profile of FM30 cells was less similar to that of AM3 cells. In FM30 cells, seven miRNAs (miR-19b, miR-320, miR-186, miR-199a, miR-339, miR-99a, and miR-152) were downregulated more than 800-fold compared with AM3 cells. It is interesting that the abundant miRNAs miR-99a and miR-152 in AM3 cells were previously found to be almost absent in LM6 (LD-MSC6L) cells derived from lipoma adipose tissue, and that the highly upregulated genes HAS2, VNN1, COL11A1, and SLC16A6 targeted by miRNAs miR-99a and/or miR-152 may be responsible for a higher proliferation potential in LM6 cells compared with AM3 cells [10, 20] .
Thirty-eight genes targeted by these six miRNAs (except miR-99a) were upregulated more than threefold in FM30 cells compared with AM3 cells, and the most abundant epiregulin gene was found to be expressed more than 1,400 times the overall mean in FM30 cells. These 38 highly expressed target genes might play an important role(s) in the development of facial tissue, and thus abdominal AM3 cells might not be suitable for tissue engineering of facial rejuvenation. Conversely, autologous abdominal AM3 cells are the most suitable for tissue restoration in breast reconstruction, since the expression profiles of mRNAs and miRNAs from abdominal AM3 and breast BM19 cells were found to be very similar. 
